Industry News

Alembic Pharmaceuticals Limited announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 mg/mL), of Spectrum Pharmaceuticals, Inc. (Spectrum).

Hetero group to invest Rs. 1000 crore in Andhra Pradesh to expand its pharmaceutical and specialist business, said Vamsi Krishna Bandi, Managing Director of Hetero.

There was Global Investors Summit 2023 organised at Visakhapatnam where he said, "We are committed to Andhra Pradesh and will continue to expand our presence here. We'll be investing about Rs 1,000 crore in Andhra Pradesh over the next two years to grow our pharmaceutical and specialty business. This will generate employment for a minimum of 3,000 people."

Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited.

HPCI Exhibition & Conference 2023 was held on 16 and 17 February, 2023 at Jio World Convention Centre, BKC, Mumbai. It was organised by ExpoNova Exhibitions & Conferences (India) Pvt. Ltd. It was focused on raw materials and techniques for the formulation of cosmetic and cleaning products. It is indeed a place where industry meets, discovers new ingredient and technology, learns about various innovation.

The governments of Gabon, Jamaica and Sri Lanka have joined forces to fight back against damaging beauty practices, launching a joint 14-million USD project to eliminate the use of mercury in skin lightening products.

Using cosmetics to inhibit the body’s production of melanin, leading the skin to appear lighter, is a centuries-old practice in many parts of the world that continues to take a toxic toll today.

Flipkart, Amazon and other online pharmacies are served notices by DCGI for selling online medicines without license. DCGI mentioned that online sales of medicine without proper license is illegal as per the order by Honorable High Court of Delhi.

Pfizer Limited announced that its Board of Directors has appointed Meenakshi Nevatia as an Additional Director and the Managing Director for a period of five years with effect from 3rd April 2023. She succeeds S.Sridhar, who announced his early retirement in August 2022.

Sun Pharma including its subsidiaries and/or associate companies) announced that one of its wholly owned subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic lenalidomide Capsules, 5mg, 10mg, 15mg, 25mg and tentative approval for 2.5mg, 20mg.

The respective product approval is based on Revlimid® Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product.

Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Dolutegravir, Emtricitabine and Tenofovir Alafenamide (DETAF) Tablets. This product would be manufactured at Lupin’s Nagpur facility in India.

DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- & middle-income countries.